NS Pharma takes on Sarepta as FDA approves DMD drugThe FDA has approved a new therapy for the rare muscle wasting disease Duchenne muscular dystrophy (DMD) as Share XNS Pharma takes on Sarepta as FDA approves DMD drughttps://pharmaphorum.com/news/ns-pharma-sarepta-fda-approves-dmd-drug/
NS Pharma steals a march on Sarepta with DMD drugJapan’s Nippon Shinyaku Pharma has filed for approval of its Duchenne muscular dystrophy (DMD) in the US, increasing Share XNS Pharma steals a march on Sarepta with DMD drughttps://pharmaphorum.com/news/ns-pharma-steals-a-march-on-sarepta-with-dmd-drug/
